The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biologic markers guiding the treatment of non-small cell lung cancer: RRM-1, class III ß tubulin, and ERCC-1.
Esat Namal
No relevant relationships to disclose
Mustafa Bozkurt
No relevant relationships to disclose
Akin Ozturk
No relevant relationships to disclose
Kezban Nur Planci
No relevant relationships to disclose
Nuray Bassullu
No relevant relationships to disclose
Ozgul Pamukcu
No relevant relationships to disclose
Gulen Bulbul Dogusoy
No relevant relationships to disclose
Sezer Saglam
No relevant relationships to disclose
Zafer Akcali
No relevant relationships to disclose
Gokhan Demir
No relevant relationships to disclose